Dirk Jäger
Impact in
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 105
- Cancer Immunotherapy and Biomarkers 31
- Pancreatic and Hepatic Oncology Research 30
- CAR-T cell therapy research 20
- Immunology 64
- Immunotherapy and Immune Responses 50
- T-cell and B-cell Immunology 18
- Co-authors
- Markus Wolfgang Büchler (29 shared papers)Oliver Strobel (10 shared papers)Alexander K. Knuth (21 shared papers)Niels Halama (27 shared papers)Jürgen Debus (15 shared papers)John P. Neoptolemos (4 shared papers)Elke Jäger (15 shared papers)Christoph Springfeld (34 shared papers)
- Journals
- Annals of Oncology (12 papers)OncoImmunology (11 papers)International Journal of Cancer (10 papers)BMC Cancer (8 papers)Oncotarget (7 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Dirk Jäger
262 papers receiving 16.7k citations
Dirk Jäger's Hit Papers
Peers
Comparison fields: 5 of 160
- Oncology 8.7k
- Immunology 4.2k
- Cancer Research 2.1k
- Health Informatics 190
- Radiology, Nuclear Medicine and Imaging 2.3k
Countries citing papers authored by Dirk Jäger
This map shows the geographic impact of Dirk Jäger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Jäger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Jäger more than expected).
Fields of papers citing papers by Dirk Jäger
This network shows the impact of papers produced by Dirk Jäger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Jäger. The network helps show where Dirk Jäger may publish in the future.
Co-authors
The 25 scholars most cited alongside Dirk Jäger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 269 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 68 Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer Hit paper breakdown → | 2019 | 1109 |
| 2 | Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial Hit paper breakdown → | 2016 | 1067 |
| 3 | Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer Hit paper breakdown → | 2019 | 993 |
| 4 | Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy Hit paper breakdown → | 2013 | 933 |
| 5 | Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study Hit paper breakdown → | 2019 | 764 |
| 6 | Optimizing the outcomes of pancreatic cancer surgery Hit paper breakdown → | 2018 | 685 |
| 7 | 1998 | 630 | |
| 8 | Pan-cancer image-based detection of clinically actionable genetic alterations Hit paper breakdown → | 2020 | 457 |
| 9 | 2016 | 407 | |
| 10 | 2000 | 404 | |
| 11 | Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction Hit paper breakdown → | 2020 | 403 |
| 12 | 2014 | 378 | |
| 13 | 2013 | 306 | |
| 14 | 2016 | 275 | |
| 15 | 1997 | 263 | |
| 16 | 2020 | 258 | |
| 17 | 2014 | 254 | |
| 18 | 2018 | 225 | |
| 19 | 2019 | 202 | |
| 20 | 2000 | 194 |
About Dirk Jäger
Dirk Jäger is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 269 papers that have together received 17.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (50 papers), Cancer Immunotherapy and Biomarkers (31 papers), Pancreatic and Hepatic Oncology Research (30 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), CAR-T cell therapy research (20 papers), Renal cell carcinoma treatment (18 papers), T-cell and B-cell Immunology (18 papers) and Virus-based gene therapy research (17 papers). The work is most often cited by research in Oncology (8.7k citations), Immunology (4.2k citations), Cancer Research (2.1k citations), Health Informatics (190 citations) and Radiology, Nuclear Medicine and Imaging (2.3k citations). Dirk Jäger has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Markus Wolfgang Büchler, Oliver Strobel, Alexander K. Knuth, Niels Halama, Jürgen Debus, John P. Neoptolemos, Elke Jäger, Christoph Springfeld, Thilo Hackert and Jakob Nikolas Kather. Their work appears in journals such as Annals of Oncology, OncoImmunology, International Journal of Cancer, BMC Cancer and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.